Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs by Brouwer, A. et al.
Characterization of Potential Endocrine-Related Health Effects at Low-Dose Levels
of Exposure to PCBs
Abraham Brouwer,1 Matthew P. Longnecker,2 Linda S. Birnbaum,3 Jim Cogliano,4 Paul Kostyniak,5 Jack Moore,6 Suzan
Schantz,7 and Gerhard Winneke8
'Division of Toxicology, Department of Food Technology and Nutritional Sciences, Wageningen Agricultural University and Research Center,
The Netherlands; 2National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina USA; 3Experimental Toxicology
Division, National Health and Environmental Effects Research Laboratories, U.S. Environmental Protection Agency, Research Triangle Park,
North Carolina USA; 4National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC USA;
5Toxicology Research Center, School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, New York USA; 6lnstitute for
Evaluating Health Risks, Washington, DC USA; 7College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois
USA; 8University of Duesseldorf, Duesseldorf, Germany
This article addresses issues related to the characterization of endocrine-related health effects
resulting from low-level exposures to polychlorinated biphenyls (PCBs). It is not intended to be a
comprehensive review of the literature but reflects workshop discussions. "The Characterizing the
Effects of Endocrine Disruptors on Human Health at Environmental Exposure Levels," workshop
provided a forum to discuss the methods and data needed to improve risk assessments of endocrine
disruptors. This article contains an overview of endocrine-related (estrogen and thyroid system)
interactions and other low-dose effects of PCBs. The data set on endocrine effects includes results
obtained from mechanistic methods/ and models (receptor based, metabolism based, and transport
protein based), as well as from in vivo models, including studies with experimental animals and
wildlife species. Other low-dose effects induced by PCBs, such as neurodevelopmental and
reproductive effects and endocrine-sensitive tumors, have been evaluated with respect to a possible
causative linkage with PCB-induced alterations in endocrine systems. In addition, studies of low-dose
exposure and effects in human populations are presented and critically evaluated. A list of
conclusions and recommendations is included. Key words: endocrine, estrogen, health, human, low
dose, PCBs, risk, thyroid. - Environ Health Perspect 1 07(suppl 4):639-649 (1999).
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A National Institute of Environmental
Health Sciences' workshop, "Characterizing
the Effects of Endocrine Disruptors on
Human Health at Environmental Exposure
Levels," was held in Raleigh, North Carolina,
on 11-13 May 1998. This workshop was
to provide a forum for the discussion on
methods and data needed to improve risk
assessments of endocrine disruptors. The dis-
cussions presented in this paper address the
persistent and toxic environmental pollutants
polychlorinated biphenyls (PCBs).
PCBs cause a wide range of effects in
experimental animals, wildlife, and humans
(1,2). This article addresses toxic effects
from low-level exposures to PCBs that may
be related to endocrine-associated influences
on health. The assigned task was a challenge,
in part because a) PCBs are a complex mix-
ture that comprise theoretically 209 con-
geners; b) the toxicity of PCBs is highly
dependent on the number and position of
chlorine atoms on the biphenyl rings; c) both
parent PCBs and their metabolites can cause
toxic effects, with the metabolites being
mainly associated with endocrine-associated
effects; and d) there is a large species differ-
ence in toxic effects of PCBs. We also recog-
nize that humans are exposed to high levels
of natural compounds in foods that may alter
the endocrine activity, if any, of PCBs in
humans. Nevertheless, much progress has
been made through the study of specific PCB
congeners and their metabolic products,
which enables an evaluation of potential
endocrine-associated adverse health effects
of PCBs.
This article is not intended to be a com-
prehensive review of the literature but
reflects workshop discussions. Only data
available from peer-reviewed articles were
considered for discussion. The following
questions were addressed:
* What data and models are needed to esti-
mate human risk?
* What is the spectrum of observed effects?
* What is the quality of the human expo-
sure data?
* What has been the utility of specific animal
and in vitro models?
The questions and discussions of these
issues are addressed in the same order, with
appropriate citations of relevant data.
Conclusions and recommendations are given
at the end of this article.
What Data and Models
Are Needed to Estimate
Human Risk?
In principle, the strategy to estimate human
risk at low-dose exposure to endocrine
disrupting chemicals does not differ from
that used for other categories of toxic
compounds in the sense that one needs
exposure-effect relationships and dose-
response data in experimental animals; in the
case of a suggested problem one may rely on
wildlife data or human epidemiologic data to
support or reject claims of exposure-related
adverse health effects. The complexity
arises, however, when considering the vast
number of different cells, tissues, and organs
that could possibly be affected when the sup-
portive endocrine system(s) are disrupted.
Consequently, many different exposure-effect
relationships may have to be studied to evalu-
ate the full spectrum of adverse effects that
could arise following endocrine disruption.
The complexity increases further when
considering that most essential physiologic
functions such as reproduction and behavior,
as well as the processes involved in fetal
development, are supported by multiple
endocrine systems that may communicate
(cross-talk) with each other. Hence, even
when a chemical affects a physiologic end
point such as reproduction or behavior, it
may be difficult to prove that this effect
results from disruption of an endocrine sys-
tem. Finally, endocrine systems can be
affected in various ways, e.g., at the receptor
level, the various metabolic steps, the organ,
processes of synthesis and/or release, the trans-
port systems, and various steps of feedback
regulation. This complicates the development
of suitable and unequivocal mechanism-
based (pre)screening and testing methods to
predict potential low-dose health risks from
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exposure to putative endocrine-disrupting
chemical compounds or mixtures.
Although it is difficult to answer the ques-
tion, What data and models are needed to
estimate human risk? based on data and expe-
riences from studies on the effects of PCBs,
the PCB database can provide valuable
insight on how to evaluate human health
risks at environmental exposure levels.
In this article, a concise overview is
given of the available data with regard to
endocrine-related effects of PCBs, including
the full spectrum of low-dose effects
observed in animals and effects in humans
following accidental or occupational expo-
sure to PCBs. An attempt is made to delin-
eate which of those low-dose end points are
to be considered as causally linked to
endocrine disruption. The information is
structured in subclasses of methods and
models used to obtain the data. Although a
lot of information on hormonal alterations
caused by PCBs was known well before
endocrine disruption became a prominent
issue, it should be noted that many of
the data sets on effects of PCBs were not
obtained originally with a focus on putative
endocrine-disruptive effects. Categorizing
data on effects of PCBs in different classes of
methods and models is therefore mainly
done in retrospect. It is, however, possible
and helpful to use this data set and the expe-
riences obtained with PCBs to assess possible
human health risks from exposure to low
levels of putative endocrine disruptors.
Overview of Endocrine-
Related and Other Low-Dose
Effects of PCBs
Endocrine Sysems Aected by PCBs
There is extensive data on endocrine-related
effects of PCBs. A wide variety of endocrine
systems are affected by PCBs, including the
estrogen and androgen system (3), the thy-
roid hormone system (4), retinoid system,
corticosteroid system and several other
endocrine pathways. In addition, the dioxin-
like non-ortho and mono-ortho PCBs that
exert their effects mainly through the arylhy-
drocarbon receptor (AhR) pathway may also
affect a number of other pathways through
cross-talk of the AhR and AhR nuclear trans-
port protein (ARNT) transcription factors
with other members of the Per-Arnt-Sim
family of helix-loop-helix proteins (5). The
work group agreed to focus their attention on
interactions of PCBs with the thyroid and
estrogen hormonal systems. The effects
observed by PCBs are subdivided into
a) endocrine effects on components of the
endocrine system such as hormones, meta-
bolic enzymes, carrier proteins, receptors,
endocrine glands, and feedback regulation
systems, and b) effects that may be associated
with changes in endocrine systems: neuro-
development, reproduction, immune effects,
and induction of endocrine-sensitive tumors.
Mechanism-Based Models for
Endocrine Effects
Mechanism-based models that are used to
study endocrine effects focus on certain
aspects of the endocrine system. The in vitro
models and methods are particularly suitable
to study certain aspects of endocrine systems
in isolation. These mechanism-based models
may be quite useful as (pre)screening tools
to identify putative endocrine-disruptive
chemicals and may allow the analysis of
large numbers of compounds in short
periods of time.
Receptor-based methods and models.
These methods and models indude receptor-
binding assays, receptor-mediated reporter
gene assays, and hormone-dependent cell
proliferation assays.
ESTROGEN RECEPTOR-MEDIATED EFFECTS
OF PCBs. Several hydroxylated (OH)-PCBs
show binding affinity for the estrogen recep-
tor in in vitro receptor-binding assays (6-8).
The most potent congener among the
limited set of hydroxy-PCBs tested was
2,4,6,2',6'-pentachloro-4-biphenylol, which
was about 5 times less potent than 17p-estra-
diol (7), although most compounds show
much less potency (6,8). A number of OH-
PCBs identified in human serum exhibited
antiestrogenic activity in the rat uterine
estrogen-binding assay and in the MCF-7
cell proliferation assay (9). OH-PCBs bound
to the estrogen receptor and transactivated
the estrogen receptor to DNA binding and
altered gene expression in in vitro reporter
gene assays (9,10). However, these com-
pounds were mainly antiestrogenic rather
than estrogenic in these reporter gene assays.
PCB mixtures (Aroclors 1221, 1232, 1242,
1248, 1254, and 1260) did not exhibit antie-
strogenic activity, based on secretion of pro-
cathepsin D, an estrogen-regulated gene in
MCF-7 cells (11).
THYROID RECEPTOR-MEDIATED EFFECTS
OF PCBS. There is little information on the
direct effects of PCBs or their metabolites
on the thyroid hormone receptor(s).
McKinney and co-workers (12) found some
indications that dioxins and dioxinlike
PCBs may bind to the nuclear thyroid hor-
mone receptor, based on graphics-assisted
computer modeling. However, to date no
report has been published showing a direct
competitive binding of PCBs to thyroid
hormone receptors.
Metabolism-based methods and models.
Many different enzyme systems are involved
in the synthesis, intracellular bioactivation,
and degradation of hormones including
cytochrome P450 isozymes, uridine-5-
diphosphate-glucuronyltransferases (UGTs),
deiodinases (IDs), and sulfotransferases
(SULTs). It is the intimate interplay between
these enzyme systems that determine the
intracellular concentrations of active hor-
mones in target cells. Certain chemicals may
affect endocrine systems by interfering in
metabolic steps and thereby altering the
availability of the active natural hormone.
EFFECTS OF PCBS ON THYROID HORMONE
METABOLISM. PCB congeners are capable of
inducing UGT enzymes in livers of exposed
rats. There are at least two or possibly three
UGT isozymes involved in thyroid hormone
glucuronidation (13). The so-called bulky
phenol types ofUGT are inducible by PCBs,
in particular by planar non-ortho-PCBs, with
the induction mechanism involving the Ah-
receptor. For example, T4 thyroxine glucuro-
nidation is markedly induced in livers of rats
exposed to 3,3',4,4'-tetrachlorobiphenyl CB
(PCB 77) (13), 3,3',4,4',5,5'-hexaCB (PCB
169) (14), 3,3',4,4',5-pentaCB (PCB 126),
and 2,3,3',4,4',5-hexaCB (PCB 156)
(15,16). However, nonplanar di-ortho PCBs,
such as 2,2',4,4',5,5'-hexaCB (PCB 153) are
also capable of inducing T4 throxine glu-
curonidation, albeit through another isozyme
(17). PCB mixtures are also capable of
inducing T4 glucuronidation (18-21). A neg-
ative correlation between plasma T4 levels
and hepatic T4 UGT activity has been
observed (17).
PCBs also affect thyroid hormone ID
enzymes as well as SULT isozymes. Exposure
of rats to 3,3',4,4'-tetraCB (PCB 77)
resulted in an inhibition of hepatic ID-1 that
converts T4 into T3 (triiodothyronine) as
well as reverse T3 activity (13,22). OH-PCB
metabolites competitively inhibited ID-1
activity in isolated rat microsomes (22,23).
On the other hand, brain ID-2 (converts T4
into T3 exclusively) was enhanced in fetal
and neonatal rats born from dams exposed to
3,3',4,4',5,5'-hexaCB (PCB 169) and
3,3',4,4'-tetraCB (PCB 77) (14). OH-PCBs
were also potent inhibitors of thyroid
hormone sulfation, competitively inhibit-
ing the SULT enzyme involved (24,25).
Inhibition of ID activity or SULT activities
may compromise the availability of
intracellular T3.
EFFECTS OF PCBs ON ESTROGEN METABO-
LISM. There is only limited information avail-
able on the effects of PCBs on estrogen
metabolism. The main enzyme system
involved in estrogen metabolism that is also
affected by dioxinlike PCBs is the cyto-
chrome P450 system. Catechol estrogen for-
mation was decreased by 50-75% in hepatic
microsomes obtained from 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (2,3,7,8-TCDD)-
treated rats (26). 2,3,7,8-TCDD and related
Environmental Health Perspectives - Vol 107, Supplement 4 * August 1999640
EVALUATING RISK FROM LOW-DOSE PCB EXPOSURE
compounds affect aromatase, thus interfering
in the production of estradiol from testos-
terone (27). Yoshihara et al. (28) reported
that 3,3',4,4',5-pentaCB (PCB 126) increased
the 7a-hydroxylation but suppressed the
2a-, 6P-, and 16a-hydroxylation and 5a-
reduction of progesterone and testosterone in
liver microsomes.
Transportprotein methods and models.
Interference with intracellular and/or plasma
proteins that transport hormones may greatly
enhance (at least momentarily) the availabil-
ity of free hormone for uptake and biological
activity. This may be particularly important
during pregnancy, when serum protein bind-
ing of hormones plays a crucial role in main-
taining a suitable level of free hormone
despite large fluctuations in hormone physi-
ology and demand. In addition, transport
protein binding may provide special facili-
tated routes of transport for exogenous
chemicals, which may have a considerable
impact on their toxicokinetics.
INTERFERENCE OF PCBs WITH THYROID
HORMONE-BINDING PROTEINS. OH-PCBs
competitively displace T4 from the plasma-
binding protein transthyretin (TTR), for-
merly known as prealbumin (29-31). This
occurs both in vitro and in vivo in fetal brain
and plasma as well as in maternal plasma.
The structure-activity relationship of T4-
TTR competition by OH-PCBs is well
known and involves hydroxylation on meta or
para positions with one, but preferably two,
adjacent halogen substituents on the phenolic
ring. It should be noted that no competitive
interaction on thyroxine-binding globulin
takes place with OH-PCBs, which may indi-
cate a lower impact of OH-PCBs on plasma
T4 levels in those species, such as humans and
nonhuman primates, possessing thyroxine-
binding globulin. The binding of OH-PCBs
to TTR may be involved in the rapid and
facilitated transfer ofOH-PCBs instead of the
natural hormone T4 across the placental and
blood-brain barriers, leading to relatively
high levels (up to micromoles) of OH-PCBs
accumulating in the fetus, particularly in the
fetal brain (32,33).
INTERFERENCE OF PCBs WITH ESTROGEN-
BINDING PROTEINS. There is very little infor-
mation on possible interference of PCBs with
estrogen-binding proteins such as sex hor-
mone-binding globulin (SHBG) or utero-
tropinlike proteins. There is, however,
information on the binding of methylsulfone-
PCB metabolites to a uterotropinlike protein
in lungs of rats (34)
All of the mechanisms indicated above
may have implications on the availability of
thyroid hormones in the fetal brain and
other tissues where thyroid hormones play an
essential role in normal development.
However, in recently performed rat perinatal
exposure studies, Aroclor 1254 resulted in
little or no effect on fetal and neonatal brain
T3 levels, despite the fact that plasma and
brain T4 levels were reduced by 90% (32).
In addition, no changes in T4-sulfate concen-
trations were observed in dams or fetuses,
despite the fact that considerable amounts of
phenolic organohalogens were present in the
fetal compartment (35).
In Vivo ModelS for Endocrine Effets
ofPCBs
Experimental animal models. THYROID
HORMONE SYSTEM EFFECTS. Most informa-
tion on thyroid hormone-related effects of
PCBs stem from relatively short-term single-
dose exposure studies of experimental
animals (rats, mice, marmoset monkeys)
exposed to either mixtures of PCBs or indi-
vidual PCB congeners. Exposure to PCB
mixtures (Aroclors 1254 and 1260, Clophen
A50) or to single PCB congeners [e.g.,
3,3',4,4'-tetraCB (PCB 77), 2,3,3',4,4'-
pentaCB (PCB 105), 2,3',4,4',5-pentaCB
(PCB 118), 3,3',4,4',5-pentaCB (PCB 126),
3,3',4,4',5,5'-hexaCB (PCB 169), or
2,2',4,4',5,5'-hexaCB (PCB 153)] resulted in
marked reductions in plasma levels of T4,
whereas T3 levels were only marginally
affected (14-16,21,36-40). Reductions in
plasma thyroid hormone levels were observed
24-48 hr after a single intraperitoneal injec-
tion and remained low for prolonged periods
of time (several days to months), depending
on the half-life of the PCB congener (36).
Effects at lower doses were observed in
experiments involving perinatal exposure pro-
tocols. For example, severely depressed T4
levels (by 60-90%) were observed in fetal and
neonatal rats following in utero exposure to 5
or 25 mg of Aroclor 1254/kg from gestation
day 10 to gestation day 16 (32), while much
higher doses of Aroclor 1254 were needed in
adult rats to cause similar changes in plasma
T4 levels (36). At postnatal day 21, there
were no observable reductions in plasma T4
levels, indicating that perinatal exposure to
PCBs did not cause permanent alterations in
thyroid hormone levels in the offspring.
Reduced plasma T4 levels were also observed
in rat pups born to dams exposed to 4 or 16
mg of 2,3',4,4',5-pentaCB (PCB 118) and 16
or 64 mg of 2,2',4,4',5,5'-hexaCB (PCB
153)/kg/day from gestation day 10 to
gestation day 16 (41).
Effects of PCB exposure on thyroid
hormone feedback regulation, as measured by
thyroid-stimulating hormone (TSH) levels, are
equivocal. Some reports indicate an increased
TSH concomitant with a low T4 level in adult
rats after exposure to PCBs (19,42,43); other
reports, mainly from in utero exposure to
PCBs, have not observed an effect on TSH
despite severely depressed T4 levels (32).
Reduced brain T4 levels (by 90%) were also
observed in fetal rats following in utero expo-
sure to Aroclor 1254 (32). However, brain T3
levels were marginally affected because of
increased activity of the enzyme ID-2, which
bioactivates T4 to the active hormone T3.
This indicates that an effective compensatory
mechanism is operative in late gestational
fetuses that may effectively cope with severely
reduced T4 levels in critical target organs such
as the brain.
Sustained alterations in peripheral
thyroid hormone levels will result in a
prolonged activation of the hypothalamic-
pituitary-thyroid (HPT) axis. Evaluation of
thyroid gland morphology may therefore be
a good indicator for compounds that inter-
fere in thyroid hormone metabolism.
Thyroid gland abnormalities have been
reported following adult and in utero expo-
sure to Aroclor 1254 in rats and adult expo-
sure in cynomolgus monkeys (44-49). The
ultrastructural lesions observed in rat thyroid
follicular cells after PCB exposure were sug-
gestive of an effect on thyroid hormone syn-
thesis and secretion (47,50). However, these
thyroid ultrastructural changes were also
interpreted as a sustained thyroid activation
through the HPT axis (41,51).
ESTROGEN SYSTEM EFFECTS. Decreases in
serum estradiol and progesterone were
reported in rhesus monkeys exhibiting repro-
ductive dysfunction, following exposure to
2,3,7,8-TCDD (500 ppt in the diet for 7
months) (52) and polybrominated biphenyls
(53). Exposure to Aroclor 1248 at doses of
2.5 and 5.0 ppm in the diet caused pro-
longed menstrual cycles and decreased peak
progesterone levels in female rhesus monkeys
(54). Aroclor 1242 caused an increase in
basal leutinizing hormone and follicle-stimu-
lating hormone secretion by the pituitary in
rats (55 ).
The uterotropic assay, e.g., an increase in
uterine wet weight in prepubertal rats follow-
ing a short-term exposure (e.g., 4 days) to an
estrogenic compound, is frequently used as a
functional assay for putative estrogenic com-
pounds. Aroclor mixtures, particularly the
lower chlorinated ones including Aroclors
1221, 1232, and 1242, were weakly estro-
genic in the uterotropic assay (55-58). The
potency of the Aroclor mixtures was 4-5
orders of magnitude lower than that of 170-
estradiol. The non-ortho 3,3',4,4'-TeCB[PCB
77] was not estrogenic and in fact antago-
nized the increases in uterine wet weight
induced by 17p-estradiol and Aroclor 1242.
ortho substitution may be related to the weak
estrogenic activity ofPCB congeners (7,58).
Studies in wildlife species. Possible
effects of putative endocrine disruptors in real
life are difficult to assess because of the gener-
ally very low background levels of exposure.
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However, studies in wildlife species that are
situated at the top of food chains may be
quite useful to establish if there are effects at
environmentally relevant concentrations.
THYROID HORMONE SYSTEM EFFECTS.
There is a considerable data set for the effects
of PCBs on wildlife species. Some studies also
provide information on thyroid hormone sys-
tem effects. Changes in plasma T4 levels were
observed in wildlife species exposed either
experimentally or environmentally to low
doses of PCBs. Harbor seals (Phoca vitulina)
held in captivity were exposed for almost 3
years to fish diets that were obtained from a
highly polluted area (Baltic Sea) or from a rel-
atively clean area (northeast Atlantic). The
diets differed by a factor of 10 in PCB con-
centrations, and feeding was adjusted for fish
protein intake (59). Seal reproduction was
reduced in the group fed the highly polluted
fish diet. In plasma samples taken from the
seals during the dietary exposure period, sig-
nificantly reduced total and free thyroxine
(TT4, FT4) and total triiodothyronine (TT3)
levels were found in the highly polluted fish
diet group (60).
Several studies have been performed on
eggs of fish-eating birds that were taken from
their nests and artificially hatched in a labora-
tory incubator. Significant dose-dependent
reductions in plasma thyroid hormone con-
centrations TT4 and FT4 were observed in
cormorant hatchlings from high PCB-
contaminated breeding colonies compared to
those from low PCB-contaminated colonies
(61). The number of hatchlings and fledg-
lings in the high-contaminated breeding
colony was significantly reduced compared to
that in the low-polluted colony. In addition,
28-day-old eider ducks exposed to 3,3',4,4'-
tetraCB (PCB-77) under semifield conditions
showed a significant negative correlation
between plasma thyroid hormone levels
T3 and T4 and liver 3,3',4,4'-tetraCB
concentrations (62)
Extensive reports have been published on
thyroid gland lesions observed in Great Lakes
fish species, where a possible linkage with
polyhalogenated aromatic hydrocarbon
(PHAH) exposure has been suggested (63).
However, other factors such as iodine defi-
ciency or non-PHAH-like waterborne goitro-
gens may have been involved. Feeding Great
Lakes fish diets to rodents resulted in thyroid
responses similar to those found in rats
exposed to PCBs (64). Thyroid enlargement
was found in several Great Lakes populations
of herring gulls sampled between 1974 and
1982 (65).
ESTROGEN SYSTEM EFFECTS. There is
little information on estrogen system effects
of PCBs in wildlife species. Adult female
mink who were fed diets containing various
PCBs 1 month prior to breeding and through
Table 1. Dose- and endocrine system-linked adverse effects induced by PCBs in experimental animals and/or their
offspring.
Effect Animal Dose level Endocrine link
Thyroid system
T4 depletion Rodents/monkeys Lowa T
T3 depletion Moderateb T
TSH increase (Adults) Low/moderate T
Thyroid gland abnormalities Rodents/monkeys Moderate T
Estrogen system
E2levels Rodents/monkeys Moderate/highc E
Uterotropic effects Rodents Low/moderate E
Growth reduction Rodents/monkeys Low/moderate T?
Neurodevelopment
Neurotransmitters (dopamine) Rodents/monkeys Moderate/high T/?
Neuroproteins (GFAP/synapt) Rats Low/moderate T/?
Neuromotor effects Rodents/monkeys Moderate/high T/?
Cognitive development Rodents/monkeys Low/moderate T/?
Auditory function Rodent Low/moderate T
Reprodevelopment
Gonad development Rodents/monkeys Low E/?
Sex differentiation Rodents Low E/?
Sex behavior Rodents/monkeys Low E/?
F1-fertility Rodents/monkeys Low/moderate E/?
Endometriosis Rodents/monkeys Low E/?
Immunotoxicity Rodents/monkeys Low ?
Endocrine tumors
Thyroid Rats High T
Mammary Rats High (reduction) Anti-E/?
Dermal lesions Monkeys Low/moderate ?
Porphyria Rodents Moderate ?
Biochemical enzyme Rodents/monkeys Low ?
induction, etc.
Abbreviations: E, estrogen system, E2, estradiol, F,, first-generation offspring; GFAP, glial fibrillary acidic protein; PCBs, polychlori-
nated biphenyls; synapt, synaptophysin; T, thyroid system; TSH, thyroid-stimulating hormone, T3, triiodothyronine; T4, thyroxine,
endocrine linkage unknown. "Lower than 1 mg/kg. blower than 50 mg/kg. cAbove 50 mg/kg PCBs.
parturition developed severe reproductive
problems and some changes in sex hormone
levels. Aroclor 1254 at 2.5 ppm in the diet
caused a decrease in plasma progesterone
(66); however, 3,3',4,4',5,5'-hexaCB (PCB
169) caused an increase in plasma pro-
gesterone. In harbor seals fed fish diets with
relatively high levels of PCBs for 2 years, a
lower reproductive success was observed;
changes in plasma levels of progesterone were
also found (59).
Other Low-Dose Effects ofPCBs in
Experimental Animals That May Be
Linked to Endocrine Disruption
PCBs induce a wide spectrum of toxic and
biochemical effects in experimental animals.
In Table 1, a number of the most important
effects are given. In addition, the effects are
categorized as low-, moderate-, or high-dose
effects and whether there is a suggested link
with endocrine disruption.
Endocrine linkage is clear for hormone
and endocrine gland-related effects. This is
not necessarily the case for the other effects
listed in this table. For most of the end
points listed in Table 1, it may be reasonable
to suggest a linkage with alterations in an
endocrine system; however, this does not
indicate that the effect is mediated by an
endocrine mechanism.
Neurodevelopmental effects. It is well
known that thyroid hormones are very
important for normal brain development and
that hypothyroidism during fetal and early
neonatal life may have profound adverse
effects on the developing brain. This may
result in reduced axonal and dendritic size
and complexity (67) and alterations in the
growth and development of a number of
different neuronal cell types and glial fibril-
lary acidic protein (GFAP)-positive astrocytes
(68). In fact, changes in GFAP levels have
been observed in several brain regions in post-
natal day 90 rat offspring that were exposed
in utero and via lactation to Aroclor 1254
(69). Hypothyroidism also results in changes
in the serotonergic and dopaminergic
neurotransmitter systems (70). It is well
known that perinatal exposure of rodents to
PCB mixtures or to dioxinlike as well as non-
dioxinlike PCBs causes changes in dopamin-
ergic and serotonergic neurotransmitter
concentrations and metabolism (71-73). In a
perinatal exposure study (74), similar influ-
ences were observed on the serotonergic
system by 3,3',4,4'-tetraCB (PCB 77) and
the well-known thyroid suppressive agent
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6-n-propyl-2-thiouracil in rat offspring.
Retarded behavioral and cognitive develop-
ment and profound deafness are conse-
quences of fetal hypothyroidism (75). Rodent
and monkey offspring born to mothers
exposed to PCBs perinatally also exhibited
learning and behavioral deficits and reduced
auditory-evoked potentials at low frequencies
(40,76-80). Although quite similar changes
in neurodevelopment can be induced by fetal
hypothyroidism and by perinatal exposure to
PHAHs, this does not necessarily mean that
the changes observed by PHAHs are causally
linked to alterations in the thyroid hormone
system. However, the changes observed in
auditory-evoked potentials are more likely
linked directly to alterations in the thyroid
hormone system (40).
Effects on reproductive development.
Gonad development, sex determination, and
reproductive success of the offspring are highly
dependent on the sex hormonal systems.
Disruption of the sex steroid system during
fetal stages of life results in profound adverse
developmental reproductive effects, as is well
known from the diethylstilbestrol experience
(3). The changes include decreased sperm
counts; sperm abnormalities; male gonadal
changes such as hypospadia, cryptorchidism,
microphallus, testicular and prostate tumors;
female gonadal changes such as ovarian cysts,
malformations of the cervical canal, ovarian
tumors, and vaginal adenocarcinoma; and
infertility in both sexes. Changes in estrogen
and androgen hormonal balances during fetal
life may also impact on gonadal as well as sex-
ual behavioral development. Alterations in
reproductive development have been most
extensively studied with 2,3,7,8-TCDD.
2,3,7,8-TCDD exposure during development
causes changes in both male and female
gonadal development, reductions in sperm
counts, abnormal sperm, and changes in sexual
behavior such as demasculinization and femi-
nization of male offspring (81,82). There is
only limited information on reproductive
developmental effects following exposure to
PCBs. Postnatal lactational exposure of infant
male rats to Arodor 1254 at maternal doses of
8, 32, and 64 mg/kg resulted in adverse effects
on subsequent mating behavior and reproduc-
tive success (83). There were also decreases in
ventral prostate weight and testicular weight in
adult male rats exposed to Aroclor 1254 via
lactation. In female rats exposed to Aroclor
1254 via lactation, several adverse effects were
observed such as delayed puberty, decreased
uterine weight, impaired fertility, and irregular
estrus cycles (84). Although the reproductive
abnormalities induced by 2,3,7,8-TCDD (and
to a more limited extent by PCBs) would not
be in conflict with an underlying estrogenlike
mechanism of action, this possible relationship
needs to be studied further.
Endocrine-sensitive tumors. It is well
known that tumor incidences of endocrine-
sensitive organs such as mammary gland,
testis, prostate, ovary, and thyroid gland can
be highly influenced by changes in sex
steroids or thyroid hormone levels. In fact,
quite a number of antitumor therapies take
advantage of this knowledge by using anti-
hormone or hormone antagonist treatments.
PCBs are carcinogenic in rodents. The
principle tumor response to 2,3,7,8-TCDD
and related dioxinlike PCBs is seen in the
female rat liver (85). The fact that no liver
tumors are observed with 2,3,7,8-TCDD in
male rat livers suggests a possible role of estro-
gens in female rat liver tumor formation by
2,3,7,8-TCDD. There is some information
on PCB-induced tumors in endocrine tissues.
Small increased incidences of thyroid gland
follicular cell adenomas were observed for
males receiving Aroclor 1242, 1254, or 1260
at 25, 50, or 100 ppm in the diet for 2 years,
but the increases did not continue propor-
tionately above the lowest dose. Follicular cell
hyperplasia (generally minimal or mild) was
increased in a nondose-related manner for
males exposed to Aroclor 1242, 1254, or
1260. Thyroid effects were not observed in
males fed 50, 100, or 200 ppm Aroclor 1016
or in female Sprague-Dawley rats fed Aroclor
1016, 1242, 1254, or 1260 (86). The
morphology of the tumors was characteristic
of those that develop as a secondary response
to chronic overstimulation by TSH.
A significant decreased trend in the
incidence of spontaneously occurring mam-
mary gland tumors was measured in female
Sprague-Dawley rats fed up to 100 ppm
Aroclors 1242, 1254, and 1260 in the diet
for 2 years. The effect was not observed in
females fed up to 200 ppm Aroclor 1016
(86). This effect was most consistently
observed in groups receiving Aroclors 1242
and 1260. The authors speculated that the
results may be the consequence of an
alteration in the 2-hydroxylation rate versus
the 16-a-hydroxylation rate of estradiol, as
reported by others and demonstrated in this
study (87). We also note that 2,3,7,8-
TCDD decreases the amount of hepatic
estrogen receptors in rats (88). Reduced
incidences of mammary tumors in rats have
been seen with studies of Aroclor 1260
in Sherman rats (89) or Sprague-Dawley
rats fed 2,3,7,8-TCDD (84), but these
may have been associated with decreases in
body weight.
These data suggest that at relatively high
doses, PCBs affect tumor incidence. This
may be related to persistent effects on the
thyroid system (hypothyroidy resulting in
prolonged overstimulation of the HPT axis)
or to effects on the estrogen system following
chronic exposure.
Exposure and Associations with Health
ects in Human Populations
Data on human exposure to PCBs. Over the
past 20 years, measurement of human expo-
sure to PCBs has improved because of devel-
opments in methods of extracting PCBs from
the specimen source and in clean-up to
remove materials that interfere with the assay;
control of the proportion of PCBs in the
source specimen that is extracted for analysis
(because of availability of deuterated or surro-
gate standards); and instrumentation that has
resulted in lower detection limits and lower
coefficients of variation.
Using modern methods it is now
apparent, that the PCBs in human specimens
typically comprise three dozen or more spe-
cific PCB congeners, with the number
detected depending on the analytical sensitiv-
ity of the laboratory method, amount of
sample, and the population studied. From
the 1970s through the mid-1980s, however,
PCBs were usually quantified by either the
peak pattern method, where PCB peaks in
the sample were compared with the corre-
sponding peaks in commercial PCB mix-
tures, or by the perchlorination method,
where all individual PCB congeners were
converted to decachlorobiphenyl, followed
by back calculation to commercial PCB
mixtures, e.g., Aroclor 1260 (1,90,91).
Subsequently, analysis of several chromato-
graphic peaks (often seven) reflecting the con-
centration of the major congeners was used to
provide a more precise estimate of total PCBs
[using the Webb-McCall method (92)].
Recently, the focus has been on quantifica-
tion of specific congeners using solid phase
(93) or solvent extraction (94). With the ear-
liest measures of PCBs. comparison of results
across laboratories is unreliable. Results based
on the Webb-McCall method allow a qualita-
tive comparison of concentrations measured
in different laboratories. With congener-spe-
cific methods, quantitative comparisons across
laboratories are feasible but still complicated
by variation across laboratories in procedures
for extraction and clean-up, methods of analy-
sis including selection of congeners measured,
and data handling and presentation.
Expressing organochlorine concentration
in relation to the amount of lipid in the speci-
mens is desirable because otherwise variation
in lipid introduces variation in wet weight
concentration that does not reflect body bur-
den. Furthermore, expressing concentration
per unit lipid probably better represents the
concentration of free organochlorine that may
be directly responsible for toxicity, much like
levels of free hormones deemphasize variation
in total concentration because of differences
in amounts of binding proteins present.
Expressing concentration of organochlorines
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relative to lipids, however, introduces another
source of variation in measurement across lab-
oratories. Not only do the major approaches
to lipid determination (gravimetric and enzy-
matic) introduce possible variation in results,
but for a given approach results may vary
substantially across laboratories.
Measurement of specific congeners has
become popular, in part, because the toxicol-
ogy of the individual PCB congeners varies.
For example, PCB congener 153, routinely
detectable in humans by modern methods,
induces phenobarbital-metabolizing enzymes
(95). Congener 28 and several others are sus-
pected of being neurotoxic. Congener 118,
also routinely detectable in humans, has weak
dioxinlike activity.
The dioxinlike activity in a sample can be
completely characterized by measurements of
PCB congeners that include those with the
most potent dioxinlike activity (congeners
with no ortho position chlorines [coplanar
PCBs]) as well as polychlorinated dibenzodi-
oxins (PCDDs; including dioxin itself), and
related compounds such as polychlorinated
dibenzofurans (PCDFs). These three types of
compounds are present at very low concentra-
tions in background-exposed people. Meas-
urement of these very low concentration
compounds is expensive and requires rela-
tively large sample volumes. Whether or not
these are measured, the total dioxinlike activ-
ity of a given sample can be estimated by tak-
ing into account the dioxinlike activity of
each individual compound and the amount
of each compound that is present (95). The
dioxinlike activity of a compound is expressed
as a toxic equivalency factor, a multiplier that
reflects the compound's dioxinlike potency
relative to dioxin (range 0-1). The sum of the
concentration of each compound multiplied
by its toxic equivalency factor yields a toxic
equivalency for the mixture.
Recent studies suggest that among back-
ground-exposed people in Europe (96) and
North America (97), levels of specific PCB
congeners, PCDDs, and PCDFs are highly
Table 2. Summary of epidemiologic data on organo-
chlorine exposure in relation to neonatal or infant thyroid
function.
Exposure location of population
measure studied (reference) n T4 TSH
PCBs Netherlands(101) 78 1 I
Netherlands (118) 93 No A NR
PCDFs/PCDDs, Netherlands (102) 38 T I
or total TEQs Netherlands (101) 78 1 I
Japan(103) 71 -1 I
Netherlands (118) 93 No A NR
Abbreviations: no A, no association; NR, not reported; PCBs,
polychlorinated biphenyls; PCDDs, polychlorinated dibenzodiox-
ins; PCDFs, polychlorinated dibenzofurans; TEQs, toxic equiva-
lents; TSH, thyroid-stimulating hormone; T4, thyroxine; I,
statistically significant direct association; JI, statistically
significant inverse association.
correlated, raising questions regarding the
additional information gained by measuring
a large number of specific PCB congeners or
related compounds, and about whether
effects of specific compounds can be distin-
guished statistically. Furthermore, methods
of grouping congeners with similar toxico-
logic properties have been proposed for use
as exposure measures in epidemiologic analy-
ses, but their value in practice remains to
be established.
Finally, we note that with PCB levels
expressed relative to the amount of lipid
present, the concentrations in various tissues
have been considered equivalent. However,
few data are available to substantiate this, and
the possibility that different congeners
equilibrate differendy has not been adequately
addressed (98).
A comment on the scope ofepidemio-
logic data reviewed. We have focused our
discussion of epidemiologic results primarily
on studies of health outcomes associated with
exposure to PCBs. We have not included a
general review of the health effects of expo-
sure to PCDDs or PCDFs, although such
data may be informative if PCBs are toxic
through an AhR-mediated mechanism.
The reader is referred elsewhere for more
information on this topic (99). We note that
studies on fish intake in relation to health
outcomes may be informative regarding PCB
effects, but such studies were in general not
included in this review because of the possi-
bility that other contaminants in fish might
account for health effects associated with fish
consumption. Two studies of fish intake in
relation to neurodevelopment outcome,
however, are included in this review. We
have focused primarily on those relations
where the data suggest an association.
Thyroid data are reviewed in detail because
of the direct tie-in with endocrine disrup-
tion. More complete recent reviews are
available elsewhere (100).
Epidemiologic associations between
early-life PCB exposure and health effects.
THYROID HORMONES. The results of the two
studies of in utero exposure to PCBs and
thyroid function in neonates are summarized
in Table 2. Both studies were done in Dutch
populations with no special PCB exposure.
The laboratory assay for TSH used in the
study by Koopman-Esseboom et al. (101)
had a lower limit of detection. In that study
higher PCB exposure was related to increased
TSH. In the small study by Pluim et al.
(102) also done among a Dutch population,
both thyroxin (T4) and TSH increased with
higher exposure to dioxin and dioxinlike
compounds. Koopman-Esseboom et al.
(101) also found that exposure to dioxin
and dioxinlike compounds was associated
with increased TSH and lower total T4. In
another study among subjects in Japan who
had no special dioxin exposure (103), expo-
sure to dioxin and dioxinlike compounds was
associated with decreased T4 and increased
TSH, measured at 1 year of age. Overall, the
results of the four modest-size studies on
Table 3. Summary of epidemiologic results on perinatal PCB or dietary fish exposure in relation to neurodevelop-
mental outcomes.a
Age outcome Location of population Effect of Exposure measure used
Outcome measured studied (reference) I PCB intake Fish Measured PCBs
Neonatal reflexes 60 hr Michigan (119) Hyporeflexia /
60 hr Michigan (119) None /
72 hr North Carolina (120) Hyporeflexia /
14 days Netherlands (121) Noneb /
36 hr New York (122) Abnormal reflexes /
Neonatal muscle tone 60 hr Michigan (119) None /
72 hr North Carolina (120) Hypotonia /
14 days Netherlands (121) Hypotoniac /
36 hr New York (122) None /
Psychomotor 6 months North Carolina (123) Delayed V/
developmentd 36 months North Carolina (124) None /
3 months Netherlands (125) Delayed /
42 months Netherlands (126) None /
Mental development 6 months North Carolina (123) None /
3 months Netherlands (125) None /
10 11 years Michigan (127) Decreased V/
Visual recognition memory 7 months Michigan (128) Decreased /
Short-term memory 4 years Michigan (129) Decreased /
4 years North Carolina (130) None /
Abbreviations: IQ, intelligence quotient; PCBs, polychlorinated biphenyls. 'Representative findings are shown from each study; for
brevity all results from each study are not included. hA relation with 'neonatal optimality score,' comprising reflex and tone compo-
nents, was found for breast-fed children with PCBs measured in breast milk. However. with PCBs in cord blood as the exposure
measure in the entire study group, including children who were not breast fed, however, a relation was not present. &1rue only in
breast-fed children, with PCBs measured in breast milk. dDutch neurologic exam findings for children (not neonates) are classified with
psychomotor development results in this table.
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early-life organochlorine exposure suggest
that associations with thyroid function exist
and specifically that higher exposure increases
TSH. The higher TSH could indicate mild
hypothyroidism, which in turn could adversely
affect neurodevelopment.
NEURODEVELOPMENT. The results of
studies of perinatal PCB or dietary fish expo-
sure in relation to neurodevelopmental out-
comes are summarized in Table 3. The
populations studied all had essentially back-
ground-level PCB exposure typical of the
region, though the range of exposure in
Michigan may have been increased some-
what due to frequent fish consumption
(104). Use of fish intake as a surrogate mea-
sure of PCB exposure should attenuate asso-
ciations due to measurement error, and
potential confounding of associations with
the fish measure by other neurotoxic conta-
minants of fish, such as methyl mercury, are
a concern. `Measured PCBs" in the right-
hand column of Table 3 refers to measure-
ments in mother's milk, cord blood,
maternal serum, etc., which are all highly
correlated (96,105). The methods of assess-
ing neurodevelopment have been somewhat
similar across cohorts. Some parallel findings
across cohorts are evident. For example, in
the North Carolina and the breast-fed
Netherlands subjects, higher PCB exposure
was associated with hypotonia at birth and
with delayed psychomotor development
within 6 months of birth. Furthermore, in
both studies the PCB-associated psychomo-
tor delays were no longer evident later in
childhood. Findings have not been consis-
tently replicated across studies, however. For
example, hypotonia at birth and subsequent
delay in psychomotor aspect of the Bayley
scales of infant development showed associa-
tions with PCB exposure in the Netherlands
and North Carolina studies (106) but not in
the Michigan study (not shown in Table 3).
Detrimental effects of PCBs on cognition
(IQ, visual recognition memory, and short-
term memory) have been suggested in the
Michigan data (Table 3), but confirmatory
findings have not been reported in other
studies to date. Despite discrepancies among
studies, overall the data suggest subtle neuro-
developmental delays observable in human
infant populations exposed in utero to
background levels of PCBs.
OTHER OUTCOMES. A host of other
outcomes have been examined in relation to
early-life PCB exposure. Generally, the results
are mixed or isolated positive findings remain
uncorroborated (100). For example, data are
mixed regarding an association of in utero
background-level exposure to PCBs with
lower birth weight and shorter gestational age
(100,107); one occupational study supports
such an association (108). The possibility of
detrimental immunologic effects has also
been raised (100).
Epidemiologic associations between
adult PCB exposure and health effects.
CANCER. In the study by Loomis et al. (109)
on occupational PCB exposure in relation to
cancer risk, a dose-response association was
found for malignant melanoma. In that
study, 88 deaths due to malignant melanoma
occurred among exposed workers. Similarly, a
meta-analysis including data from all earlier
studies of cancer among those occupationally
exposed to PCBs (100) also showed an
increased risk of skin cancer. That study, in
comparison, included only 15 deaths from
skin cancer of all types. Previously, the can-
cers most suspected of being linked to occu-
pational PCB exposure were liver, brain, and
malignant melanoma. The results of Loomis
et al. (109) and the meta-analysis are incon-
sistent with one another regarding whether
risk is increased for cancer of the liver. At
best, both provide weak support for increased
risk of brain cancer.
Among nonoccupationally exposed
women, the relation of PCB blood levels to
risk of breast cancer has been examined in a
number of large studies (110-113). Overall
the data do not support an association. In a
recent prospective study among subjects with
background-level exposure to PCBs, a strong
monotonic relation was observed between
blood levels of PCBs and subsequent increased
risk of non-Hodgkin lymphoma (114).
OTHER OUTCOMES. Occupational
exposure to PCBs has consistently been asso-
ciated with abnormal liver function tests and
chloracne (99). In men occupationally
exposed to PCBs, thyroid hormone level
bore no clear relation to measured PCB
levels (115). As with early-life exposures, a
host of other outcomes have been examined
in relation to PCB exposure. Generally, the
results are mixed or isolated positive findings
remain uncorroborated.
THE ASIAN (YUSHO/YU-CHENG) MASS
POISONINGS. Mass poisonings with PCB-
containing mixtures have occurred twice-
once in Taiwan and once in Japan (116,117).
In each instance contaminated rice oil was the
source. The contaminating mixture contained
PCBs, PCDFs, and other related compounds.
The toxic effects of the mixture could be due
to dioxinlike activity, with PCDFs the major
contributor, or to effects mediated by other
mechanisms of potential importance, as the
mixture contained primarily PCBs. Studies of
the health effects in these incidents are infor-
mative about high-dose adult and in utero
exposures to the mixtures. Much of the avail-
able data on health effects are from case series
and may reflect findings in the most severely
affected. The standardized morality ratio for
the studied, exposed adult populations in
Table 4. Effects observed in infants born to mothers
with Yu-cheng.
Small for gestational age More otitis media
Small head circumference Increased porphyrin
excretion
Hyperpigmentation of skin Psychomotor delays
Skin desquamation Hypotonia
Black color of nose Hypo/hyperreflexia
Deformed nails Cognitive deficits
(IQ down 5 points)
Swelling of eyelid Menstrual irregularities
Respiratory distress Hair loss
More bronchitis
IQ, intelligence quotient.
Taiwan (n-1900) and Japan (n -1800) 10
and 20 years after the incident, respectively,
was 1.1 in both populations. Deaths from
nonmalignant liver disease were increased in
both populations. In Japan an excess of
deaths from liver cancer was evident (99). In
both populations, the exposed subjects had
increased prevalence of chloracne, localized
hyperpigmentation, abnormalities of the der-
mal tissues adjacent to the eye, slowed nerve
conduction, abnormalities of a number of
laboratory tests on blood, and other symp-
toms. A group of exposed subjects from
Japan had elevated T3 and T4 levels 16 years
later (116).
The Taiwanese children exposed to the
mixture in utero were systematically followed
and studied. Within 4 years of birth, 21%
had died. The children had many of the
same manifestations of toxicity as the adults,
and in addition had delayed, inhibited
growth, permanent intellectual impairment,
disordered behavior, more frequent infec-
tions, and other problems (117). Table 4 is a
list of the major findings in the children born
to Yu-cheng mothers. Several of the symp-
toms in human infants resemble the develop-
mental effects observed in experimental
animals exposed in utero to PCBs. It is not
known if the reproductive, cognitive, and
psychomotor effects and the hearing difficul-
ties have been linked with possible endocrine
disruptive effects of PCBs in the Yu-cheng
and Yusho infants.
Summary and Conclusions
After extensive discussions of the available
peer-reviewed literature, the working group
on PCBs arrived at the following conclusions:
* Numerous effects of PCBs have been
demonstrated in experimental animals,
some of which can be induced at tissue
concentrations not far from body burdens
that are present in background exposure
populations in industrialized countries.
* The most sensitive time window of
sensitivity for adverse effects by PCBs
appears to be the prenatal and the early
postnatal period.
Environmental Health Perspectives * Vol 107, Supplement 4 * August 1999 645
BROUWER ETAL
* Developmental effects on neurobehavior,
on the reproductive tract, and on the
immune and thyroid systems are induced
following exposure to some PCBs in the
prenatal and early postnatal periods in
experimental animals.
* In human infants from accidentally
exposed populations (Yusho/Yu-cheng),
developmental effects were caused by pre-
natal exposure to PCDFs or PCBs and
induded retarded growth, neurobehavioral
effects, immune effects, chloracne, and
teeth and nail deformities.
* In several studies involving human infants
at background environmental exposure
levels, subtle changes were observed in
thyroid hormone levels and neurobehav-
ioral parameters, associated mainly, but
probably not exclusively, with prenatal
exposure to PCBs.
However, it should be noted that there
were some inconsistencies in the neurobe-
havioral and thyroid hormone findings in
the human infant studies, which emphasizes
the need for further investigations.
In the following paragraphs information
on effects of PCBs on endocrine systems and
in experimental animals, wildlife, and in
human individuals is evaluated and used to
answer the questions raised at the outset of
the workshop.
What Data and Models Are Needed to
Estimate Human Risk?
Extensive data from experimental animal
studies and data from a modest number of
human populations are available to estimate
human risk from PCB exposure. However,
the question is considerably more difficult to
answer when we are asked to estimate
human risk from endocrine-based effects of
PCBs specifically. Several endocrine systems
are affected by PCBs and their hydroxylated
metabolites. Most information is available
on thyroid hormone perturbations; however,
the estrogen, androgen, and other systems
may also be affected by PCBs. In experimen-
tal animal studies, reductions in thyroid hor-
mone levels have been observed in addition
to developmental effects on brain, behavior,
and reproduction following developmental
exposure to PCBs. Although it is tempting
to propose an endocrine linkage for the
adverse effects, there is evidence only for
selected end points. Also, in human infants,
associations have been demonstrated
between serum or human milk PCB levels
and thyroid hormone and neurobehavioral
changes. However, these findings do not
necessarily imply that neurobehavioral
changes are also causally related to thyroid
changes. Therefore, it is reasonable to con-
clude that we do not currently have the data
and models that could answer the question
on estimates of human risks from low-dose
endocrine-related effects.
One of the major problems is that
multiple PCB congeners may impact upon
multiple endocrine systems, and several of
those endocrine systems may be involved in
regulating and maintaining the same end
point. Given the complexity of PCB mix-
tures in environmental exposures, it is
unlikely that a single endocrine perturbation
will exclusively drive all of the observed
adverse effects. End points such as auditory
thresholds, which seem to be more exclu-
sively regulated by thyroid hormones, may
be good candidates for further development
into models for low-dose endocrine (thyroid
hormone)-related effects. Another problem
is the complexity and differences in the mix-
tures of PCBs that are available commer-
cially, that are present in the environment,
or are measured in human samples, e.g.,
human milk. Different compositions may
result in different spectra of toxicity out-
comes. Models using defined reconstituted
mixtures, relevant to human exposure, may
enhance the consistency of findings between
different laboratories.
What Is the Q!zality ofthe
HumanE Data
(Dose, Timing
Although we have voluminous data on PCBs
in several studies, the quality of the exposure
data from the various human cohorts studied
is highly variable. In some cases there is
extensive data on congener-specific PCB,
PCDD, and PCDF analysis in repetitive
samples taken from the same individual over
time; in others there may be only a sum PCB
measure or just fish consumption data. The
methodology used for analyzing PCBs by
different laboratories varies greatly. This
includes issues such as lipid-adjusted (gravi-
metrically or triglyceride/cholesterol basis) or
wet-weight adjusted, differences in limits of
detection, types and numbers of congeners
analyzed, etc.
Although there is extensive research
literature on the effects of PCBs, failure to
adequately describe the test substance or ver-
ify the nominal test concentration compro-
mises the utility of some results. Another
limitation is the relatively small range of
exposure levels within a given human study;
this hampers the establishment of significant
dose-response relationships. Intercalibration
of laboratory analyses may allow comparisons
between several cohorts with different
background exposure levels.
What Is the Sptrum of
Obs d Effet?
The reader is referred to the tables and text
presented in this paper.
What Has Been the Utility ofSpecific
Animal and in Vkru Models?
In general, the animal data have been
extremely useful in establishing biologic plau-
sibility and suggesting directions for human
studies. In vitro and in vivo models have been
pivotal in the advancement of our under-
standing of mechanism(s) of action, of dose-
response relationships, of susceptibility differ-
ences between strains or species, of critical
time windows of exposure and effects, and on
hazard identification in general. Studies using
wildlife species are of value in assessing health
effects when observed effects can be shown
not to be due to concomitant exposures.
Recommendations
Confirmation and extension of previous
findings in humans should be further investi-
gated. Areas of focus should include neuro-
developmental, thyroid, immunologic, and
reproductive effects.
Studies assessing the relation between
early-life PCB exposure, thyroid hormone
levels, and sensorineural hearing impairment
in children are needed. If changes in sensori-
neural hearing impairment are observed,
children should be followed to determine if
early impairment results in later deficits in
verbal ability.
End points that are more exclusively
regulated by single hormonal influences,
such as sensorineural hearing and thyroid
hormone regulation, should be further
studied and developed into validated models
for in vivo tests for potential effects of
endocrine disruptors.
Given the complex nature of mixtures of
PCBs that human individuals are exposed to
and the dependency of toxic outcome to the
congener composition of mixtures, it is
essential to design and distribute environ-
mentally relevant reconstituted PCB mix-
tures to improve comparability of studies and
consistency of results.
A research priority is for studies in
appropriate animal models (including
wildlife animal models) to determine if there
is a causal relationship between PCB con-
geners, endocrine changes, and developing
neurologic parameters. Characterization of
dose-response relationships should be a
central objective of such studies.
When interpreting study results that
appear to be key to establishing an effect (or
lack of effect), the quality and completeness
of the characterization of the test materials
should be part of the interpretation.
Analytical chemical criteria should be devel-
oped to aid in the objective analysis of such
data. The analytical criteria should promote
consistency among studies in the PCB con-
geners measured, with detailed methodology
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and quality assurance/quality control infor-
mation presented for all studies. Details on
methods of PCB determination for individ-
ual congeners, including recoveries and limits
of detection, should be reported. The
method of lipid determination and adjust-
ment should be included. For truncated data,
the number of samples included in any aver-
aged data set should be stated and the meth-
ods used to deal with values below the limit
of detection must be explained.
Because the distribution of PCB con-
geners varies with lipid content, this distribu-
tion must be determined in order to apply a
lipid adjustment to a particular sample matrix
to be used as an indication of body burden.
Ideally, a proficiency program would be
established to certij all laboratories performing
congener-specific analyses. Proficiency samples
would be available for all relevant sample
matrices, including serum, plasma, whole
blood, milk, fat, and relevant tissues as
needed. Proficiency would be demonstrated
by participating laboratories on a regular basis.
Each matrix would contain the analytes at
concentrations normally encountered in pop-
ulation studies. Lipid analysis would be
included in the proficiency program.
Vectors of exposure and the resulting
levels of PCBs in human populations need
to be characterized more fully. There is little
data on foods that include meats, fish, fruits
and vegetables, processed foods, beverages,
etc. The contribution from inhalation expo-
sures, both indoor and outdoor, need to
be characterized.
Characterization of congener distribu-
tions in human tissues of interest is needed,
especially for the OH- and sulfonated
PCB metabolites.
Interlaboratory quality control of exposure
data should stimulate the interactions and
comparability of data from various study
cohorts with different background exposure
levels to PCBs. This will enhance the quality
of estimates of dose-response relationships.
Issues of analytical quality and composition
of mixtures for experimental studies should be
coordinated by a working group under the
auspicies of an international orgamization.
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